Prometheus Biosciences, Inc. Quarterly General and Administrative Expense in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Prometheus Biosciences, Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2020 to Q1 2023.
  • Prometheus Biosciences, Inc. General and Administrative Expense for the quarter ending March 31, 2023 was $13.4M, a 65.6% increase year-over-year.
  • Prometheus Biosciences, Inc. General and Administrative Expense for the twelve months ending March 31, 2023 was $45M, a 43.6% increase year-over-year.
  • Prometheus Biosciences, Inc. annual General and Administrative Expense for 2022 was $39.7M, a 39.4% increase from 2021.
  • Prometheus Biosciences, Inc. annual General and Administrative Expense for 2021 was $28.5M, a 157% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $45M $13.4M +$5.31M +65.6% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $39.7M $12.1M +$4.65M +62.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-28
Q3 2022 $35.1M $10.3M +$24K +0.23% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $35.1M $9.32M +$3.7M +65.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $31.4M $8.09M +$2.86M +54.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $28.5M $7.42M +$3.7M +99.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 $24.8M $10.2M +$7.08M +223% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $17.7M $5.62M +$3.81M +210% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $13.9M $5.22M +$2.84M +119% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $11.1M $3.72M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $3.17M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.81M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $2.39M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.